RecruitingPhase 3NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Sponsor: Novartis Pharmaceuticals
Bellaire, TX · Corpus Christi, TX · Euless, TX · +17 more sites